Randomized Control Trial of Peer-Delivered, Modified Directly Observed Therapy for HAART in Mozambique
- 1 October 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 46 (2), 238-244
- https://doi.org/10.1097/qai.0b013e318153f7ba
Abstract
Objective: To assess the efficacy of a peer-delivered intervention to promote short-term (6-month) and long-term (12-month) adherence to HAART in a Mozambican clinic population. Design: A 2-arm randomized controlled trial was conducted between October 2004 and June 2006. Participants: Of 350 men and women (≥18 years) initiating HAART, 53.7% were female, and 97% were on 1 fixed-dose combination pill twice a day. Intervention: Participants were randomly assigned to receive 6 weeks (Monday through Friday; 30 daily visits) of peer-delivered, modified directly observed therapy (mDOT) or standard care. Peers provided education about treatment and adherence and sought to identify and mitigate adherence barriers. Outcome: Participants' self-reported medication adherence was assessed 6 months and 12 months after starting HAART. Adherence was defined as the proportion of prescribed doses taken over the previous 7 days. Statistical analyses were performed using intention-to-treat (missing = failure). Results: Intervention participants, compared to those in standard care, showed significantly higher mean medication adherence at 6 months (92.7% vs. 84.9%, difference 7.8, 95% confidence interval [CI]: 0.0.02, 13.0) and 12 months (94.4% vs. 87.7%, difference 6.8, 95% CI: 0.9, 12.9). There were no between-arm differences in chart-abstracted CD4 counts. Conclusions: A peer-delivered mDOT program may be an effective strategy to promote long-term adherence among persons initiating HAART in resource-poor settings.Keywords
This publication has 46 references indexed in Scilit:
- Editorial Commentary:Adherence to Antiretroviral Therapy: How Much Is Enough?Clinical Infectious Diseases, 2006
- Assessing Antiretroviral Adherence via Electronic Drug Monitoring and Self-Report: An Examination of Key Methodological IssuesAIDS and Behavior, 2006
- From Directly Observed Therapy to Accompagnateurs: Enhancing AIDS Treatment Outcomes in Haiti and in BostonClinical Infectious Diseases, 2004
- Efficacy of an Educational and Counseling Intervention on Adherence to Highly Active Antiretroviral Therapy: French Prospective Controlled StudyHIV Research & Clinical Practice, 2003
- A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.Health Psychology, 2003
- Evaluation of Adherence to Antiretroviral Therapy in Italian HIV PatientsAIDS Patient Care and STDs, 2003
- A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.Health Psychology, 2003
- Self-Reported Adherence to Antiretroviral Treatment and Degree of Sense of Coherence in a Group of HIV-Infected PatientsAIDS Patient Care and STDs, 2002
- Virologic Outcome and Predictors of Virologic Failure of Highly Active Antiretroviral Therapy Containing Protease InhibitorsAIDS Patient Care and STDs, 2001
- The CES-D ScaleApplied Psychological Measurement, 1977